BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Whole Exome Sequencing Advancements in Unraveling Rare Diseases in Japan

The Rare Disease Diagnosis and Intractable Disease Research Center at Juntendo University has improved its diagnostic capabilities by combining research ...

December 11, 2023 | News

PRISM BioLab and Lilly Enter into a Drug Discovery Collaboration on a Protein-Protein Interaction Target

Collaboration focused on discovering oral inhibitors of protein-protein interaction (PPI) targets by leveraging PRISM BioLab's proprietary PepMetics®...

November 29, 2023 | News

Pfizer and Astellas' XTANDI® Approved by U.S. FDA in Earlier Prostate Cancer Treatment Setting

Astellas Pharma Inc. announced that the companies received an approval by the U.S. Food and Drug Administration (FDA) of a supplemental New Drug Appl...

November 27, 2023 | News

Fujitsu Licenses Topological Data Analysis Tech to Bay Area Startup Delight Health for Mental Health Solutions

Fujitsu Limited and Delight Health, a Bay Area startup, announced that Fujitsu will license its Topological Data Analysis (TDA) technology to Delight...

November 20, 2023 | News

ASP Japan G.K. Significantly Expands Product Portfolio for Sterilization Monitoring

ASP Japan G.K., a leading company in the field of infection control, announced the introduction of a new product portfolio of sterilization monitoring prod...

November 20, 2023 | News

Ajinomoto Group Makes Strategic Move into Gene Therapy with $750 Million Acquisition of Forge Biologics, Bolstering Healthcare Portfolio for Exponential Growth

In the Medium-Term ASV Initiatives 2030 Roadmap, announced in February this year, Ajinomoto Co. identified four strategic growth areas including Healthcare...

November 15, 2023 | News

Thermo Fisher & Boehringer Ingelheim Join Forces for NSCLC Companion Diagnostics in Japan and the US

To support emerging precision therapies and improve patient outcomes by increasing access to reliable genomic testing needed to match patients with targete...

October 20, 2023 | News

Fujitsu and TOPPAN Holdings collaborate to expand medical big data business

Fujitsu Limited and TOPPAN Holdings Inc. concluded a business alliance agreement to jointly promote the medical big data business with the aim of pro...

October 20, 2023 | News

Aculys Pharma's Positive Phase 3 Update on Diazepam Nasal Spray for Epileptic Seizures in Japan

These results are from Japan's first domestic Phase 3 clinical trial of an intranasally administered antiepileptic drug for Japanese patients a...

October 19, 2023 | News

Fujitsu and RIKEN develop AI drug discovery technology utilizing generative AI to predict structural changes in proteins

Fujitsu Limited and the HPC- and AI-driven Drug Development Platform Division of the RIKEN Center for Computational Science today announced that they have ...

October 11, 2023 | News

Fujirebio and Sysmex Enter into Basic Agreement on Business Collaboration in the Field of Immunoassay

Sysmex has built up a robust technological foundation as well as a global network in the in vitro diagnostics field through developing its busine...

October 11, 2023 | News

Sony Announces Launch of FP7000 Spectral Cell Sorter Supporting High-Parameter Sorting with More Than 44 Colors(*1)

Sony Corporation announced the launch of FP7000 spectral cell sorter that supports high-speed, high-parameter sorting with more than 44 colors with s...

October 10, 2023 | News

Takara Bio enters into a license agreement of RetroNectin® with Fondazione Telethon ETS

The technologies licensed to Telethon are based on Takara Bio’s proprietary RetroNectin® method, which includes a technology enabling highly effi...

October 05, 2023 | News

Everest Medicines' Partner Calliditas Shares NefIgArd Phase 3 Trial Data at ISIN Tokyo 2023

"The positive findings from biomarker and patient subgroup analyses from the Phase 3 NefIgArd study highlights that Nefecon® treatment results in ...

October 05, 2023 | News

Stay Connected